Jazz Pharmaceuticals plc — Director's Dealing 2010

Dec 2, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-11-30

Reporting Person: Wissel Janne LT (SVP, Chief Regulatory Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-30	Common Stock	J	1391	$.85	Acquired	107221	Direct

Footnotes

F1: Shares acquired through a qualified Section 423 Employee Stock Purchase Plan.